抗肾病蛋白自身抗体在激素抵抗型肾病综合征中或可指导治疗策略
该多中心队列研究检测了儿童激素敏感型、激素依赖型、非遗传性及遗传性激素抵抗型肾病综合征中的抗肾病蛋白自身抗体。结果显示抗体阳性率在激素敏感型最高(68%),激素抵抗型较低(非遗传性14%,遗传性2%),且非遗传性激素抵抗型中抗体阳性者均对强化免疫抑制治疗有反应。
要点
- 抗肾病蛋白抗体在激素敏感型肾病综合征中阳性率最高,支持其驱动该亚型。
- 非遗传性激素抵抗型中,抗体阳性者均对强化免疫抑制治疗有反应。
- 遗传性激素抵抗型抗体阳性率极低,提示基因突变是主要病因。
核心结论
- 抗肾病蛋白抗体在激素敏感型肾病综合征中阳性率显著高于激素抵抗型,提示其主要驱动激素敏感型/依赖型。
- 非遗传性激素抵抗型中,抗体阳性与对强化免疫抑制治疗的反应相关。
研究设计与样本
- 多中心队列研究,检测儿童激素敏感型、激素依赖型、非遗传性及遗传性激素抵抗型肾病综合征样本中的抗肾病蛋白自身抗体。
主要发现
- 激素依赖型患者阳性率为28%(19/67)。
- 非遗传性激素抵抗型患者阳性率为14%(14/103)。
- 遗传性激素抵抗型患者阳性率为2%(1/62)。
- 非遗传性激素抵抗型活动期患者中,对强化免疫抑制治疗有反应者阳性率为18%(13/74),而多重耐药者阳性率为0%(0/17)。
临床怎么用
- 抗肾病蛋白抗体或可作为儿童肾病综合征的阳性预后标志物,提示对免疫抑制治疗反应良好。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Autoantibodies against the podocyte protein nephrin were recently identified in a pediatric cohort primarily comprising steroid-sensitive (SSNS) and steroid-dependent (SDNS) nephrotic syndrome (NS). However, their prevalence across all NS subtypes, particularly in steroid-resistant nephrotic syndrome (SRNS), and their relation to therapy response need to be determined to advance pathophysiological understanding and refine treatment strategies. METHODS: A multicenter cohort study measuring anti-nephrin autoantibodies in samples from children with SSNS, SDNS, nongenetic and genetic SRNS was conducted. RESULTS: Sixty-nine of 101 (68%) patients with SSNS, 19 of 67 (28%) patients with SDNS, 14 of 103 patients (14%) with non-genetic SRNS, and 1 of 62 patients (2%) with genetic SRNS were positive for anti-nephrin autoantibodies. The prevalence of anti-nephrin autoantibodies increased with presence of active disease in cases of SSNS and SDNS. Within the group of non-genetic SRNS patients with active disease, anti-nephrin positivity was found in 13 of 74 (18%) patients responding to intensified immunosuppression compared to none of 17 patients with multidrug-resistant SRNS. CONCLUSIONS: The prevalence of anti-nephrin antibodies is substantially higher in children with steroid responsive NS than in those with SRNS, suggesting that anti-nephrin antibodies primarily drive SSNS/SDNS. In contrast, NS due to podocyte gene mutations is primarily genotype-caused. Anti-nephrin autoantibodies may serve as a positive prognostic marker in pediatric NS, indicating a favorable response to immunosuppressive therapy.
引用
- Hengel FE, Dehde S, Yilmaz A, et al. Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy. Kidney Int. 2025. PMID: 39922375. doi:10.1016/j.kint.2025.01.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。